Sale!

PLA2G5 Gene Fleck retina familial benign Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “PLA2G5 Gene Fleck Retina Familial Benign Genetic Test” is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the PLA2G5 gene. This gene is associated with a rare, non-progressive retinal condition known as Fleck Retina of Kandori, which is characterized by the presence of multiple yellow-white flecks scattered throughout the retina. These flecks typically do not affect vision, making the condition benign. The genetic test is crucial for families with a history of this retinal anomaly, as it helps in confirming the diagnosis, understanding the inheritance pattern, and making informed decisions about family planning. The test is priced at 4400 AED and is conducted using state-of-the-art genetic sequencing technologies to ensure accurate results. DNA Labs UAE is a leading facility in the region, known for its expertise in genetic diagnostics and personalized healthcare solutions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PLA2G5 Gene Fleck Retina Familial Benign Genetic Test

Welcome to DNA Labs UAE, a leading genetic laboratory offering advanced genetic testing services. In this blog post, we will discuss the PLA2G5 gene Fleck retina familial benign genetic test, including its components, cost, sample condition, report delivery time, method, test type, doctor, and test department. We will also explore the importance of pre-test information, test details, and the benefits of genetic testing for Fleck retina familial benign.

Test Name: PLA2G5 Gene Fleck Retina Familial Benign Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ophthalmology Disorders

Doctor: Ophthalmologist

Test Department: Genetics

Pre Test Information

Prior to undergoing the PLA2G5 Gene Fleck retina familial benign genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the PLA2G5 Gene Fleck retina familial benign NGS Genetic DNA Test gene PLA2G5.

Test Details

The PLA2G5 gene is associated with Fleck retina familial benign, a rare inherited eye disorder that affects the retina, the light-sensitive tissue at the back of the eye. This disorder is characterized by small, yellow-white spots (flecks) scattered throughout the retina. While these flecks typically do not impact vision, they may cause mild vision impairment in some cases.

NGS genetic testing is a type of genetic testing that utilizes next-generation sequencing technology to analyze multiple genes simultaneously. This comprehensive analysis of an individual’s genetic makeup enables the identification of genetic mutations associated with specific diseases or conditions.

A genetic test for the PLA2G5 gene can aid in the diagnosis of Fleck retina familial benign in individuals displaying symptoms or with a family history of the condition. Furthermore, this test can identify carriers of the genetic mutation, providing valuable information for family planning and genetic counseling.

It is important to note that genetic testing is not always necessary for diagnosing Fleck retina familial benign, and other diagnostic tests may be used in conjunction with genetic testing to confirm a diagnosis. Additionally, it is essential to discuss the potential benefits and risks of genetic testing with a healthcare provider, as it may not be covered by insurance and can be costly.

Thank you for reading our blog post on the PLA2G5 Gene Fleck Retina Familial Benign Genetic Test. For more information or to schedule a test, please contact DNA Labs UAE.

Test Name PLA2G5 Gene Fleck retina familial benign Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PLA2G5 Gene Fleck retina, familial benign NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PLA2G5 Gene Fleck retina, familial benign NGS Genetic DNA Test gene PLA2G5
Test Details

The PLA2G5 gene is associated with Fleck retina, familial benign, which is a rare inherited eye disorder that affects the retina, the light-sensitive tissue at the back of the eye. This disorder is characterized by small, yellow-white spots (flecks) that are scattered throughout the retina. These flecks do not usually affect vision, but in some cases, they may cause mild vision impairment.

NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze multiple genes at once. This type of testing can provide a comprehensive analysis of an individual’s genetic makeup, allowing for the identification of genetic mutations that may be associated with certain diseases or conditions.

A genetic test for the PLA2G5 gene can help diagnose Fleck retina, familial benign in individuals who have symptoms of the disorder or have a family history of the condition. This test can also be used to identify carriers of the genetic mutation, which can be helpful for family planning and genetic counseling.

It is important to note that genetic testing is not always necessary for the diagnosis of Fleck retina, familial benign, and other diagnostic tests may be used in conjunction with genetic testing to confirm a diagnosis. Additionally, genetic testing may not be covered by insurance and can be costly, so it is important to discuss the potential benefits and risks with a healthcare provider before undergoing testing.